2023. 8. 7, 코리아 헤럴드 Efforts are underway to consider sex differences in drug development by increasing woman’s participation in clinical trials, but the lack of regulatory guidelines remains a barrier to taking gender diversity into account, experts say. 기사 보기 (영문) >>